Kythera’s (KYTH) Double Chin Drug Kybella Gets FDA Nod
Pipeline and regulatory updates are highly awaited events in the pharma/biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight into the commercial potential of the candidate once it is successfully developed and commercialized. Last week, Kythera Biopharmaceuticals, Inc. […]